Activation of human mitochondrial pantothenate kinase 2 by palmitoylcarnitine
- 30 January 2007
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 104 (5), 1494-1499
- https://doi.org/10.1073/pnas.0607621104
Abstract
The human isoform 2 of pantothenate kinase (PanK2) is localized to the mitochondria, and mutations in this protein are associated with a progressive neurodegenerative disorder. PanK2 inhibition by acetyl-CoA is so stringent (IC50 < 1 microM) that it is unclear how the enzyme functions in the presence of intracellular CoA concentrations. Palmitoylcarnitine was discovered to be a potent activator of PanK2 that functions to competitively antagonize acetyl-CoA inhibition. Acetyl-CoA was a competitive inhibitor of purified PanK2 with respect to ATP. The interaction between PanK2 and acetyl-CoA was stable enough that a significant proportion of the purified protein was isolated as the PanK2.acetyl-CoA complex. The long-chain acylcarnitine activation of PanK2 explains how PanK2 functions in vivo, by providing a positive regulatory mechanism to counteract the negative regulation of PanK2 activity by acetyl-CoA. Our results suggest that PanK2 is located in the mitochondria to sense the levels of palmitoylcarnitine and up-regulate CoA biosynthesis in response to an increased mitochondrial demand for the cofactor to support beta-oxidation.This publication has 33 references indexed in Scilit:
- Prokaryotic Type II and Type III Pantothenate Kinases: The Same Monomer Fold Creates Dimers with Distinct Catalytic PropertiesStructure, 2006
- Coenzyme A: Back in actionProgress in Lipid Research, 2005
- Altered Neuronal Mitochondrial Coenzyme A Synthesis in Neurodegeneration with Brain Iron Accumulation Caused by Abnormal Processing, Stability, and Catalytic Activity of Mutant Pantothenate Kinase 2Journal of Neuroscience, 2005
- Deficiency of pantothenate kinase 2 ( Pank2 ) in mice leads to retinal degeneration and azoospermiaHuman Molecular Genetics, 2004
- Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden‐Spatz syndrome) and pantothenate kinase‐associated neurodegenerationMovement Disorders, 2004
- Role of Feedback Regulation of Pantothenate Kinase (CoaA) in Control of Coenzyme A Levels in Escherichia coliJournal of Bacteriology, 2003
- An isoform of hPANK2, deficient in pantothenate kinase-associated neurodegeneration, localizes to mitochondriaHuman Molecular Genetics, 2003
- Defects of mitochondrial β-oxidation: a growing group of disordersNeuromuscular Disorders, 2002
- Effects of hypoxia and fatty acids on the distribution of metabolites in rat heartBiochimica et Biophysica Acta (BBA) - Bioenergetics, 1990
- CARNITINEAnnual Review of Biochemistry, 1988